Stefanou DT, Bamias A, Episkopou H, Kyrtopoulos SA, Likka M, Kalampokas T, Photiou S, Gavalas N, Sfikakis PP, Dimopoulos MA, et al. Aberrant dna damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancer. PLoS ONE [Internet]. 2015;10(2).